ABL Diagnostics Targets Drug-Resistant Tuberculosis with Advanced Diagnostic Tools

Paris, Friday, 20 March 2026.
On March 20, 2026, ABL Diagnostics expanded its portfolio to target drug-resistant tuberculosis, introducing advanced sequencing solutions that unlock new revenue streams in the infectious disease market.